P/E ratio for Adicet Bio (ACET)

P/E ratio history for Adicet Bio from 2020 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Novartis NVS	31.2	-11,788.27%	🇨🇭 Switzerland
Pfizer PFE	38.8	-14,650.47%	🇺🇸 USA
Merck MRK	150	-56,180.69%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	68.1	-25,609.91%	🇮🇱 Israel
Hawkins HWKN	37.5	-14,143.97%	🇺🇸 USA
Quaker Houghton KWR	27.8	-10,527.94%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.